Related News
Sharry Veres, MD, Named One of Phoenix Business Journal’s Outstanding Women in Business
Tuesday, April 30, 2024
Pharmacogenomics Symposium Showcased Progress and Potential in the Field
Tuesday, April 23, 2024
9th Annual Research Conference Highlights Innovation and Discoveries from Across the Valley
Thursday, April 18, 2024City Sun Times
The Arizona Department of Health Services will add Narcan, the naloxone medication that rapidly reverses the effects of opioid overdose, to the automated external defibrillator boxes at its office in downtown Phoenix. "We hope other offices, sports arenas and healthcare facilities will also start having naloxone available for the public to use in case of an opioid overdose," said Steve Dudley, PharmD, director of the Arizona Poison and Drug Information Center at the University of Arizona and a member of the Center for Toxicology and Pharmacology Education and Research at the college. "These kits will surely save more lives as we continue to battle this epidemic."
About the College
Founded in 2007, the University of Arizona College of Medicine – Phoenix inspires and trains exemplary physicians, scientists and leaders to optimize health and health care in Arizona and beyond. By cultivating collaborative research locally and globally, the college accelerates discovery in a number of critical areas — including cancer, stroke, traumatic brain injury and cardiovascular disease. Championed as a student-centric campus, the college has graduated more than 800 physicians, all of whom received exceptional training from nine clinical partners and more than 2,700 diverse faculty members. As the anchor to the Phoenix Bioscience Core, which is projected to have an economic impact of $3.1 billion by 2025, the college prides itself on engaging with the community, fostering education, inclusion, access and advocacy.